Roivant Sciences (ROIV) EBT Margin (2020 - 2025)
Historic EBT Margin for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to 14525.71%.
- Roivant Sciences' EBT Margin fell 119252100.0% to 14525.71% in Q4 2025 from the same period last year, while for Dec 2025 it was 16606.06%, marking a year-over-year decrease of 383675000.0%. This contributed to the annual value of 2346.02% for FY2025, which is 163094500.0% down from last year.
- As of Q4 2025, Roivant Sciences' EBT Margin stood at 14525.71%, which was down 119252100.0% from 10123.74% recorded in Q3 2025.
- Roivant Sciences' EBT Margin's 5-year high stood at 33116.21% during Q4 2023, with a 5-year trough of 14525.71% in Q4 2025.
- Over the past 5 years, Roivant Sciences' median EBT Margin value was 2503.44% (recorded in 2022), while the average stood at 2462.91%.
- As far as peak fluctuations go, Roivant Sciences' EBT Margin soared by 353568700bps in 2023, and later crashed by -357167100bps in 2024.
- Over the past 5 years, Roivant Sciences' EBT Margin (Quarter) stood at 1257.33% in 2021, then tumbled by -78bps to 2240.66% in 2022, then skyrocketed by 1578bps to 33116.21% in 2023, then plummeted by -108bps to 2600.5% in 2024, then crashed by -459bps to 14525.71% in 2025.
- Its EBT Margin was 14525.71% in Q4 2025, compared to 10123.74% in Q3 2025 and 12408.39% in Q2 2025.